New frontiers in contraceptive research : a blueprint for action
Author(s)
Bibliographic Information
New frontiers in contraceptive research : a blueprint for action
National Academies Press, c2004
- : pbk
Available at 3 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references
Description and Table of Contents
Description
More than a quarter of pregnancies worldwide are unintended. Between 1995 and 2000, nearly 700,000 women died and many more experienced illness, injury, and disability as a result of unintended pregnancy. Children born from unplanned conception are at greater risk of low birth weight, of being abused, and of not receiving sufficient resources for healthy development. A wider range of contraceptive options is needed to address the changing needs of the populations of the world across the reproductive life cycle, but this unmet need has not been a major priority of the research community and pharmaceutical industry. New Frontiers in Contraceptive Research: A Blueprint for Action, a new report from the Institute of Medicine of the National Academies, identifies priority areas for research to develop new contraceptives. The report highlights new technologies and approaches to biomedical research, including genomics and proteomics, which hold particular promise for developing new products. It also identifies impediments to drug development that must be addressed. Research sponsors, both public and private, will find topics of interest among the recommendations, which are diverse but interconnected and important for improving the range of contraceptive products, their efficacy, and their acceptability.
Table of Contents
Front Matter
Executive Summary
1 Introduction
2 Target Discovery and Validation
3 Product Identification and Development
4 Improving Contraceptive Use and Acceptability
5 Capitalizing on Recent Scientific Advances
Appendix A: Examples of Progress and Impediments in Contraceptive
Research and Development
Appendix B: Agendas and Participants in Committee Workshops
Appendix C: Committee Biographies
Glossary
Acronyms
Table of Contents
- 1 Front Matter
- 2 Executive Summary
- 3 1 Introduction
- 4 2 Target Discovery and Validation
- 5 3 Product Identification and Development
- 6 4 Improving Contraceptive Use and Acceptability
- 7 5 Capitalizing on Recent Scientific Advances
- 8 Appendix A: Examples of Progress and Impediments in Contraceptive Research and Development
- 9 Appendix B: Agendas and Participants in Committee Workshops
- 10 Appendix C: Committee Biographies
- 11 Glossary
- 12 Acronyms
by "Nielsen BookData"